Search
Research outputs
Impact of age of subjects on the efficacy and safety of once-daily oral obefazimod in moderately to severely active ulcerative colitis: week 8 results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials [2026]
Magro, F; Tilg, H; Cataldi, F; Jacobstein, D; Rabbat, C; Shan, K; Nancey, S; Markovic, S; Rocco, R; Harlacher, L;
Yarur, A;
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY) [2025]
Colombel, Jean Frederic; ...; Sreckovic, Slobodan; ...; (broj, koautora 33)A unique clinical phenotype of primary sclerosing cholangitis associated with Crohns disease [2012]
Halliday, J. S.; Đorđević, Jelena D.; Lust, M.; Culver, E. L.; Braden, B.; Travis, S. P. L.; Chapman, R. W. G.The effect of antiTNF alpha and anti-integrin agents on liver steatosis in inlamatory bowel disease patients with non-alcoholic fatty liver disease [2023]
Mitrovic, M; Markovic, Srdjan T; Kalaba, Ana; Zaric, Dusan; Kralj, D; Milic, A; Svorcan, Petar VCerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents [2015]
Karmiris, Konstantinos; ...; Tarabar, Dino K; ...; (broj, koautora 20)Assessment of body composition parameters in patients with inflammatory bowel disease treated with biological therapy
[2024]
Spirić, Jelena; Topličanin, Aleksandar; Vuksanović, S.; Nikolić, Andreja; Jovičić, Ivana A.; Đuranović, Srđan P. 
; Popović, Dragan ; Đelić, Marina ; Dragašević, Sanja ; Sokić-Milutinović, Aleksandra D.
Long term efficacy and safety for Sequential Rescue Treatments in patents with steroid refractory Ulcerative Colitis - Two years follow up data [2015]
Protic, Marijana B; Frei, Pascal; Manser, C; Knezevic, Tamara; Mottet, Christian; Juillerat, Pascal; Markovic, S; Beglinger, Christoph; Jojic, Njegica Z; Vavricka, Stephan;
Rogler, Gerhard; Seibold, Frank;
Maintenance of Inflammatory Bowel Disease remission after switching from iv to sc administration of infliximab - a prospective single center cohort study [2026]
Ocepek, A; Bukovnik, N; Pernek, R; Velkovski, C; Homsak, E; Putnikovic, D ; Nikolic, S
Maintaining remission after an episode of steroid-responsive Acute Severe Ulcerative Colitis: what is the best strategy? [2025]
Bravo, C; ...; Milenkovic, Z; ...; (broj, koautora 40)Human Papillomavirus Epidemiology in Anti-TNFα-Treated Women: Contrasting Patterns Between Inflammatory Bowel Disease Patients and Rheumatoid Arthritis [2026]
Mitrovic, M; Knezevic, T; Kalaba, A; Odanovic, O; Kralj, D; Markovic, SFilters
By type
- 76